Jeffrey J. Brown - 03 Feb 2023 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
03 Feb 2023
Net transactions value
+$67,608
Form type
4
Filing time
09 Feb 2023, 20:06:00 UTC
Previous filing
12 Jan 2023
Next filing
05 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Purchase $1,289 +11 +0.47% $114.97 2,377 07 Feb 2023 Direct F1
transaction MED Common Stock Purchase $59,857 +516 +1.4% $116.11 37,014 03 Feb 2023 By Brown Equity Partners, LLC F2, F3
transaction MED Common Stock Purchase $6,462 +56 +1.4% $116.11 3,996 03 Feb 2023 Jeffrey Brown Living Trust F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.
F2 The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F3 The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member.
F4 The shares were acquired by the Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F5 These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.